Company intelligence / Profile preview

One Health Summit

Palo Alto, California, United States

Ownership: Private
Development stage: Other

Overview

The One Health Company is a biotechnology firm that bridges veterinary and human oncology through its precision medicine platform, FidoCure. By providing genomic sequencing and personalized targeted therapies for dogs with cancer, the company improves pet outcomes while generating high-quality longitudinal data to accelerate human drug development. FidoCure leverages FDA-approved human drugs for canine use, creating a "One Health" ecosystem that benefits both species. The company is backed by top-tier investors like Andreessen Horowitz and Y Combinator and collaborates with institutions such as Johns Hopkins University.

Therapeutic areas: Oncology
Modalities: Small moleculeDiagnostics
Industry: Biotech

Partnerships

Johns Hopkins University School of MedicineStanford University

Beyond the preview

Go deeper on One Health Summit.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on One Health Summit.

Explore the full profile